We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+1.54%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.84B
AUM Growth
+$1.62B
(+22%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
19.13%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
656
New
169
Increased
202
Reduced
101
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rithm Capital
RITM
|
+$78.4M |
| 2 |
Infosys
INFY
|
+$65M |
| 3 |
F5
FFIV
|
+$64.6M |
| 4 |
Western Digital
WDC
|
+$62.1M |
| 5 |
Cigna
CI
|
+$60.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$69.1M |
| 2 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$68.2M |
| 3 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$57.6M |
| 4 |
Medtronic
MDT
|
+$51.8M |
| 5 |
DRC
DRESSER-RAND GROUP INC
DRC
|
+$50.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.28% |
| 2 | Healthcare | 13.44% |
| 3 | Technology | 12.36% |
| 4 | Financials | 10.47% |
| 5 | Energy | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMPV
201
DELISTED
Imperva, Inc.
IMPV
| $12.1M | 0.14% |
178,116
-115,770
| -39% | -$6.39M |
|
|
OXFD
202
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $12M | 0.14% |
866,026
+14,029
| +2% | +$190K |
|
203
PUT
Broadcom
AVGO
$2T
| $12M | 0.14% |
+900,000
| New | +$11.8M |
|
204
Xerox
XRX
$424M
| $12M | 0.14% |
+426,266
| New | +$13.2M |
|
205
James River Group Holdings
JRVR
$221M
| $11.9M | 0.13% |
460,736
+33,703
| +8% | +$807K |
|
206
Manitowoc
MTW
$510M
| $11.9M | 0.13% |
+671,296
| New | +$12.2M |
|
207
Citigroup
C
$224B
| $11.9M | 0.13% |
215,700
-196,193
| -48% | -$10.7M |
|
|
208
PUT
Citigroup
C
$224B
| $11.9M | 0.13% |
215,700
| – | – |
|
|
SEE
209
DELISTED
Sealed Air
SEE
| $11.9M | 0.13% |
+231,408
| New | +$11.1M |
|
210
CALL
Merck
MRK
$317B
| $11.8M | 0.13% |
+217,774
| New | +$12.2M |
|
|
211
PUT
Merck
MRK
$317B
| $11.8M | 0.13% |
+217,774
| New | +$12.2M |
|
212
Allot
ALLT
$372M
| $11.6M | 0.13% |
1,614,708
+313,616
| +24% | +$2.55M |
|
213
Adtran
ADTN
$611M
| $11.4M | 0.13% |
704,435
-122,673
| -15% | -$2.1M |
|
214
Sanmina
SANM
$11B
| $11.3M | 0.13% |
558,085
-181,780
| -25% | -$3.97M |
|
215
CSX Corp
CSX
$93.9B
| $11.2M | 0.13% |
1,029,186
-622,410
| -38% | -$7.21M |
|
216
Nucor
NUE
$61.9B
| $11M | 0.12% |
+250,000
| New | +$12M |
|
|
GWB
217
DELISTED
Great Western Bancorp, Inc.
GWB
| $11M | 0.12% |
+455,548
| New | +$10.7M |
|
|
SAVE
218
DELISTED
Spirit Airlines, Inc.
SAVE
| $10.9M | 0.12% |
175,014
+11,808
| +7% | +$805K |
|
219
Acadia Healthcare
ACHC
$2.86B
| $10.5M | 0.12% |
+134,546
| New | +$9.68M |
|
|
FRAN
220
DELISTED
Francesca's Holdings Corporation
FRAN
| $9.79M | 0.11% |
60,552
+26,164
| +76% | +$5.05M |
|
221
RingCentral
RNG
$5.18B
| $9.56M | 0.11% |
517,230
-350,434
| -40% | -$6.1M |
|
|
BMR
222
DELISTED
BIOMED REALTY TRUST INC
BMR
| $9.52M | 0.11% |
492,008
+83,089
| +20% | +$1.72M |
|
|
BKI
223
DELISTED
Black Knight, Inc. Common Stock
BKI
| $9.51M | 0.11% |
+308,144
| New | +$8.9M |
|
224
Union Pacific
UNP
$175B
| $9.44M | 0.11% |
+98,961
| New | +$10.3M |
|
|
EMC
225
CALL
DELISTED
EMC CORPORATION
EMC
| $9.24M | 0.1% |
350,000
-625,000
| -64% | -$16.7M |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q2 2015 Portfolio in Review
As of Q2 2015, Alyeska Investment Group held 656 positions worth $8.84B, up 22% from $7.22B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Alyeska Investment Group deployed $1.69B of net new capital in Q2 2015, opening 169 new positions and adding to 202 existing holdings. Its largest new stake was Infosys: 8,002,538 shares worth $63.4M.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Ciena, an estimated $33.5M trimmed.
- Alyeska Investment Group's largest Q2 2015 buy was Infosys: 8,002,538 shares worth $63.4M.
- Alyeska Investment Group added most to Rithm Capital in Q2 2015, an estimated $78.4M increase.
- Alyeska Investment Group's biggest Q2 2015 reduction was Ciena, cutting an estimated $33.5M.
- Alyeska Investment Group fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $69.1M.
- Alyeska Investment Group's ten largest holdings make up 18% of its $8.84B portfolio in Q2 2015.
- Alyeska Investment Group opened 169 new positions and closed 175 in Q2 2015.
- Alyeska Investment Group's portfolio value rose 22% quarter-over-quarter to $8.84B.
Based on Alyeska Investment Group's 13F filing for Q2 2015, filed 14 Aug 2015.